ICG-loaded nanoparticles are not merely delivery tools, but rather integrated theranostic systems that combine targeted drug release, precision photodynamic therapy, and immune activation—laying the groundwork for more effective and safer next-generation cancer therapies.
Fu et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: